Coordinating Center of Excellence in Social Promotion of Health Equity Research

健康公平研究社会促进卓越协调中心

基本信息

项目摘要

The mission of the Research Core of our CCE-SPHERE is to provide the leadership, infrastructure, oversight, and support to facilitate and guide the development and execution of research projects that will have a direct impact on health disparities in the African American (AA) population of South Carolina (SC), and ultimately the United States. Furthermore, the Research Core, through its interactions with the other CCE-SPHERE Cores will promote the translation of its research findings to the community to have the greatest impact possible on health disparities. Over the past 4 years, our current COE has focused its research efforts on human papillomavirus (HPV) and cervical cancer and HIV/AIDS. In this COE renewal application we are expanding our research focus to include head and neck cancer, some of which is caused by HPV. As with cervical cancer and HIV/AIDS, there is a large disparity in head and neck cancer, especially among AA males, with their age-adjusted mortality rate for oral and pharyngeal cancer almost 3-fold greater in AA men than in European American (EA) men (1). Three research projects are proposed in our COE renewal application. These projects focus on HPV-mediated disease (cervical cancer. Project 1, and head and neck cancer. Project 2) and HIV/AIDS (Project 3). Our research team has many years of experience with cervical disease caused by HPV, using both in vitro models and studies involving human populations, the latter supported by the current COE. In this competitive renewal application we have expanded our current HPV research team to include a physician scientist. Dr. Lisa Spiryda and a recent Ph.D. graduate with training in CBPR, Dr. Jessica Bellinger. Dr. Spiryda directs a colposcopy clinic that serves a population that is about 70% AA and includes women of all ages. Dr. Spiryda has observed that AA women in her population present with high-grade lesions more often than EA women. The collaboration with Dr. Spiryda will allow us to extend the observations we made (during the current funding period) in the Carolina Women's Care Study (CWCS) of a different high risk (HR) HPV type distribution between AA and EA women to an older population where CIN2-3 lesions are much more frequent and clinically relevant. Access to this population will allow us to ascertain whether the different prevalence of individual HR-HPV types we observed in the younger women in our studies is reflected in the HSIL cases in older women, and therefore assess the full range of clinical and epidemiological significance of these observations, particulariy for the potential effectiveness of HPV vaccination in AA women, since currently available HPV vaccines only target HR HPV16 and HPV18. We have also included Dr. Marion Boyd Gillespie and his collaborators at the Medical University of South Carolina (MUSC), whose interests are on HPV-mediated head and neck cancers. Together with Dr. Gillespie and Sutkowski, we will apply our knowledge of HPV-mediated transformation in the cervix and our experience with population studies of HPV persistence and infection to studies of the pathogenesis and determinants of HPVmediated oropharyngeal cancers, with particular attention to those risk factors and genetic determinants that are at the basis of the racial disparities between AA and EA men in this type of cancer. Our research team also recognizes the implications of the social determinants of health in understanding racial and ethnic health disparities and the need to translate the science of HPV-mediated diseases to the community. Dr. Jessica Bellinger, an AA post-doc with the SC Rural Health Research Center, University of South Carolina Arnold School of Public Health (ASPH), will bring a translational piece to Project 1 that will allow the team to begin to examine issues of racial bias and discrimination as social determinants of health. Projects 1 and 2 are designed to share personnel, methodology and resources and interact with one another, one informed by the findings of the other, and both have an important need for statistical support. Therefore, in this COE Renewal application, we have also added to our team Dr. Matteo Bottai, an expert biostatistician at the ASPH, as a key member of our research team. Our HIV/AIDS research team is equally as experienced as our HPV-mediated disease team from a communitybased research perspective in rural/minority health disparities and their qualitative data analysis expertise. Dr. Donna Richter is a nationally recognized researcher on HIV prevention and women's health issues. She leads the CDC/ASPH Institute for HIV Prevention Leadership (IHPL), now in its tenth year. Dr. Richter has used qualitative methods in many of her projects and has been a trainer on NVivo. She has conducted CBPR on HIV-related knowledge, attitudes, beliefs, and behaviors among the adult population in Africa and in the US working with the National AIDS Program and local community-based organizations on HIV prevention initiatives. Dr. Saundra Glover has studied cost and access to care issues for the dually diagnosed (HIV and mental illness). She has also partnered with the Sexually Transmitted Disease (STD) Division of the SC DHEC to facilitate train the trainer sessions on partner notification for individuals testing positive for HIV/AIDS. Dr. Glover has also served as faculty with the HIV/AIDS Prevention Leadership Institute under Dr. Richter's leadership. Dr. Medha Vyavaharkar has neariy ten years of experience nationally and internationally in providing care as well as conducting research among rural, African-American women with HIV disease. Dr. Vyavaharkar also has experience designing, conducting, analyzing, interpreting, and reporting qualitative research findings. Dr. Bankole Olatosi rounds out our HIV/AIDS research team. He is a young, African American health services researcher, trained at USC under Dr. Glover. Dr. Olatosi worked as a field investigator for the HRSA-funded Care Assessment Demonstration project on HIV/AIDS in Minneapolis. His work documenting that a high proportion of PLWHA living in SC do not remain in care provided the impetus for the current research project.
我们的CCE-SPHERE研究核心的使命是

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rebecca Bullard-Dillard其他文献

Rebecca Bullard-Dillard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rebecca Bullard-Dillard', 18)}}的其他基金

Role of HPV in Head and Neck Cancer in African Am & European Am Patients
HPV 在非洲美洲头颈癌中的作用
  • 批准号:
    8630892
  • 财政年份:
    2014
  • 资助金额:
    $ 18.64万
  • 项目类别:
HPV Type Distribution and Biomarkers of Cervical Neoplasia Progression in Africa
非洲 HPV 类型分布和宫颈肿瘤进展的生物标志物
  • 批准号:
    8630891
  • 财政年份:
    2014
  • 资助金额:
    $ 18.64万
  • 项目类别:
HPV Type Distribution and Biomarkers of Cervical Neoplasia Progression in Africa
非洲 HPV 类型分布和宫颈肿瘤进展的生物标志物
  • 批准号:
    8580134
  • 财政年份:
    2013
  • 资助金额:
    $ 18.64万
  • 项目类别:
Reducing"Not in Care" Status among PLWHA in Rural So Carolina
减少南卡罗来纳州农村地区感染者的“不在护理”状态
  • 批准号:
    8580138
  • 财政年份:
    2013
  • 资助金额:
    $ 18.64万
  • 项目类别:
Role of HPV in Head and Neck Cancer in African Am & European Am Patients
HPV 在非洲美洲头颈癌中的作用
  • 批准号:
    8580137
  • 财政年份:
    2013
  • 资助金额:
    $ 18.64万
  • 项目类别:
INBRE: CLAFLIN U: FACULTY AND UNDERGRADUATE RESEARCH DEVELOPMENT
INBRE:CLAFLIN U:教师和本科生研究发展
  • 批准号:
    8168150
  • 财政年份:
    2010
  • 资助金额:
    $ 18.64万
  • 项目类别:
INBRE: CLAFLIN U: FACULTY AND UNDERGRADUATE RESEARCH DEVELOPMENT
INBRE:CLAFLIN U:教师和本科生研究发展
  • 批准号:
    7959586
  • 财政年份:
    2009
  • 资助金额:
    $ 18.64万
  • 项目类别:
INBRE: CLAFLIN U: FACULTY AND UNDERGRADUATE RESEARCH DEVELOPMENT
INBRE:CLAFLIN U:教师和本科生研究发展
  • 批准号:
    7720395
  • 财政年份:
    2008
  • 资助金额:
    $ 18.64万
  • 项目类别:
INBRE: CLAFLIN U: FACULTY AND UNDERGRADUATE RESEARCH DEVELOPMENT
INBRE:CLAFLIN U:教师和本科生研究发展
  • 批准号:
    7610025
  • 财政年份:
    2007
  • 资助金额:
    $ 18.64万
  • 项目类别:
INBRE: CLAFLIN U: FACULTY AND UNDERGRADUATE RESEARCH DEVELOPMENT
INBRE:CLAFLIN U:教师和本科生研究发展
  • 批准号:
    7381400
  • 财政年份:
    2006
  • 资助金额:
    $ 18.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了